Also known as: marijuana stroke risk · cannabis-associated stroke · cannabis cerebrovascular events

Cannabis and Stroke Risk in Young Adults

A look at what current evidence says about cannabis use, ischemic stroke, and cerebrovascular events in people under 50.

Sourced and fact-checked
11 cited sources
Published 3 hours ago
How this page was made
↯ The honest take

This isn't reefer-madness territory anymore. Multiple large observational studies now link frequent cannabis use to higher stroke risk in adults under 50, even after adjusting for tobacco. The effect isn't huge in absolute terms for any one person, but it's consistent enough that 'cannabis is harmless' is no longer a defensible claim. The mechanism likely involves vasospasm, blood pressure spikes, and reversible cerebral vasoconstriction syndrome — not THC being directly 'toxic' to the brain. Smoked cannabis carries the clearest signal. Edibles and occasional use are less studied.

Plain-language summary

Strokes in young adults are rare but rising, and cannabis is one of several risk factors that researchers have flagged over the past decade. Large studies of hospital data and national health surveys have found that people who use cannabis frequently — especially daily or near-daily smokers — have a higher rate of ischemic stroke (the kind caused by a blocked artery) than non-users of similar age [1][2][3]. The increase is not enormous, and most young cannabis users will never have a stroke. But the signal is consistent across multiple datasets and survives adjustment for tobacco, alcohol, and cardiovascular risk factors [2][3].

The biology is still being worked out. Leading hypotheses involve transient blood pressure changes, heart rate spikes, vasospasm of cerebral arteries, and a condition called reversible cerebral vasoconstriction syndrome (RCVS) that has been repeatedly linked to cannabis in case series [4][5].

This article is not medical advice. If you have stroke symptoms (face drooping, arm weakness, speech difficulty), call emergency services.

What the evidence actually shows

Ischemic stroke, frequent users — Strong evidence (observational). A 2024 analysis of the U.S. Behavioral Risk Factor Surveillance System covering more than 430,000 adults found that daily cannabis use was associated with roughly 25% higher odds of stroke compared to non-use, after adjustment [3]. Earlier large studies in younger hospitalized populations showed similar directional results [1][2]. These are observational, so they can't prove causation, but the consistency across independent datasets is meaningful.

Hemorrhagic stroke — Weak / limited. Some case series and smaller cohort studies suggest an association with intracerebral hemorrhage, but the data are sparser and confounded by co-use of stimulants and tobacco [6].

Reversible cerebral vasoconstriction syndrome (RCVS) — Weak / limited but biologically suggestive. RCVS presents with thunderclap headache and can cause stroke. Cannabis is among the most commonly reported triggering exposures in case series, alongside SSRIs and sympathomimetics [4][5].

Smoking vs. other routes — Weak / limited. Most studies don't separate smoked, vaped, and edible use cleanly. The strongest signals are in smokers, raising the question of whether combustion products, THC dose, or both are responsible [2].

What probably contributes (proposed mechanisms)

No single mechanism is proven, but the candidates are plausible and overlap:

None of this proves cannabis causes strokes in any individual. It explains why the statistical association is biologically credible.

What doesn't hold up or is unclear

What we don't know

Randomized trials on this question are unlikely for ethical and logistical reasons, so the field will keep depending on large cohort and registry studies.

How this compares with other modifiable stroke risk factors

For perspective, the relative risk increase associated with frequent cannabis use in young adults is broadly comparable to — and often smaller than — that associated with:

Standard medical management of young-adult stroke risk focuses on blood pressure control, lipid management when appropriate, smoking cessation, screening for atrial fibrillation and patent foramen ovale, and treating clotting disorders. Cannabis cessation is increasingly being added to that list in clinical guidance, particularly after a cryptogenic stroke or RCVS episode [4].

If you've had a stroke or TIA and use cannabis, this is a conversation worth having with a neurologist — not a reason to panic, but a real variable to put on the table.

Risks and harm-reduction notes

If you choose to use cannabis and want to be thoughtful about cerebrovascular risk:

This is not medical advice. It's a summary of the published evidence as of writing. Your clinician knows your history; an encyclopedia doesn't.

Sources

  1. Peer-reviewed Westover AN, McBride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Archives of General Psychiatry. 2007;64(4):495-502.
  2. Peer-reviewed Parekh T, Pemmasani S, Desai R. Marijuana use among young adults (18-44 years of age) and risk of stroke: a Behavioral Risk Factor Surveillance System survey analysis. Stroke. 2020;51(1):308-310.
  3. Peer-reviewed Jeffers AM, Glantz S, Byers AL, Keyhani S. Association of cannabis use with cardiovascular outcomes among US adults. Journal of the American Heart Association. 2024;13(5):e030178.
  4. Peer-reviewed Ducros A. Reversible cerebral vasoconstriction syndrome. The Lancet Neurology. 2012;11(10):906-917.
  5. Peer-reviewed Singhal AB, Hajj-Ali RA, Topcuoglu MA, et al. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Archives of Neurology. 2011;68(8):1005-1012.
  6. Peer-reviewed Hemachandra D, McKetin R, Cherbuin N, Anstey KJ. Heavy cannabis users at elevated risk of stroke: evidence from a general population survey. Australian and New Zealand Journal of Public Health. 2016;40(3):226-230.
  7. Peer-reviewed Sidney S. Cardiovascular consequences of marijuana use. Journal of Clinical Pharmacology. 2002;42(S1):64S-70S.
  8. Peer-reviewed Goyal H, Awad HH, Ghali JK. Role of cannabis in cardiovascular disorders. Journal of Thoracic Disease. 2017;9(7):2079-2092.
  9. Peer-reviewed Moir D, Rickert WS, Levasseur G, et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chemical Research in Toxicology. 2008;21(2):494-502.
  10. Peer-reviewed Sultan SR, Millar SA, England TJ, O'Sullivan SE. A systematic review and meta-analysis of the haemodynamic effects of cannabidiol. Frontiers in Pharmacology. 2017;8:81.
  11. Government U.S. Centers for Disease Control and Prevention. Stroke risk factors. National Center for Chronic Disease Prevention and Health Promotion, 2023.

How this page was made

Generation history

May 14, 2026
Fact-check pass — raised 3 flags
May 14, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.